Lacosamid Desitin (Lacosamide)

Lacosamide is an antiepileptic drug that acts on neuronal sodium channels to control seizure activity.

• Partial‑onset seizures: adjunctive therapy reduces seizure frequency in patients with focal epilepsy.
• Focal epilepsy: improves overall seizure control when added to existing antiepileptic regimens.
• Adjunctive epilepsy treatment: used alongside other antiepileptic drugs to enhance therapeutic outcomes.

• Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing hyperexcitable neuronal membranes and reducing repetitive neuronal firing. By selectively targeting the slow inactivation phase, it limits the propagation of abnormal electrical activity without markedly affecting normal neuronal function.

Lacosamide may cause a range of adverse reactions, ranging from mild to serious.

Common Side Effects

• Dizziness: sensation of light‑headedness or unsteadiness.
• Nausea: mild to moderate stomach upset.
• Fatigue: feeling unusually tired or weak.
• Headache: mild to moderate pain in the head region.
• Somnolence: increased sleepiness or drowsiness.
• Vision changes: blurred or double vision.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm, especially in patients with pre‑existing heart conditions.
• Atrioventricular block: impaired electrical conduction between atria and ventricles.
• Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.
• Hypersensitivity: anaphylactic reactions requiring immediate medical attention.
• Elevated liver enzymes: potential indication of hepatic stress.
• Seizure worsening: paradoxical increase in seizure frequency in rare cases.

When using Lacosamid Desitin, consider the following safety measures.

• Cardiac monitoring: assess ECG in patients with known heart disease before initiation.
• Dose adjustment: modify dosage in renal or hepatic impairment as clinically indicated.
• Concomitant drugs: review all medications for potential interactions, especially other antiepileptics.
• Pregnancy: avoid use unless the potential benefit justifies the risk; data are limited.
• Breastfeeding: discontinue if adverse effects are observed in the infant.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Lacosamide can interact with several medicines, influencing its efficacy or safety.

Major Interactions (Avoid)

• CYP3A4 inhibitors: strong inhibitors may increase lacosamide plasma levels, raising toxicity risk.
• Cardiac conduction drugs: concurrent use with other agents that affect AV nodal conduction can precipitate arrhythmias.

Moderate Interactions (Monitor Closely)

• Other antiepileptics: may require dose adjustments to maintain seizure control.
• CNS depressants: additive sedation or dizziness may occur.
• Diuretics: potential alterations in electrolyte balance affecting cardiac function.